Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
- Conditions
- Congestive Heart Failure
- Registration Number
- NCT00043758
- Brief Summary
The purpose of this study is to study the effects of tolvaptan on the size and function of the left heart chamber (ventricle) in patients with congestive heart failure (CHF)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 170
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (40)
Desert Cardiology of Tucson
🇺🇸Tucson, Arizona, United States
Arkansas Heart
🇺🇸Little Rock, Arkansas, United States
San Diego Cardiac Center
🇺🇸San Diego, California, United States
Northern California Medical Associates
🇺🇸Santa Rosa, California, United States
Cardiovascular Consultants Medical Group, Inc.
🇺🇸Walnut Creek, California, United States
University of Colorado
🇺🇸Denver, Colorado, United States
The Hoffman Heart Institute of CT/St. Francis Hospital
🇺🇸Hartford, Connecticut, United States
Yale University
🇺🇸New Haven, Connecticut, United States
Cardiology Associates of Fort Lauderdale
🇺🇸Fort Lauderdale, Florida, United States
Cardiovascular Research Center of South Florida
🇺🇸Miami, Florida, United States
Scroll for more (30 remaining)Desert Cardiology of Tucson🇺🇸Tucson, Arizona, United States